Researchers are excited about this new drug, a novel dual treatment showing promising outcomes in clinical trials for body reduction . It acts by targeting two pathways : GLP-1 and GIP, which , when https://sidneyyurv143939.csublogs.com/48587504/a-new-prospect-for-body-reduction